Cascadian Therapeutics, Inc. Underwriting Agreements
8 Contracts & Agreements
- 1,818 Shares CASCADIANTHERAPEUTICS, INC. Series E Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2017)
- 23,182,000 Shares CASCADIAN THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 24, 2017)
- 35,000,000 Shares CASCADIAN THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 23, 2016)
- 1,333 Shares ONCOTHYREON INC. Series B Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2015)
- 13,500,000 Shares ONCOTHYREON INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2015)
- 10,000 Shares ONCOTHYREON INC. SeriesA Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on September 18, 2014)
- 10,000,000 Shares ONCOTHYREON INC. CommonStock UNDERWRITING AGREEMENT (Filed With SEC on September 18, 2014)
- 11,750,000 Shares ONCOTHYREON INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 29, 2012)